sellWeak cluster of 3
Scott M. Giacobello sold $6,594 of WHWK
CHIEF FINANCIAL OFFICER at Whitehawk Therapeutics, Inc.. 2,806 shares at an average of $2.35, traded Mar 3, 2025, filed Mar 3, 2025.
Warning score
27Value
$6,594
2,806 shares
Holdings after
23,944
-10% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +22RoleCFO
- 0Trade size$7k at market
- +5Share of holdings soldSold 10% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001415889-25-006318, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 1, 2025 | MOption exercise Common Stock | +6,750 | - | - | 26,750 | Mar 3, 2025 |
| Mar 3, 2025 | SOpen-market sale Common Stock | -2,806 | $2.35 | $6,594 | 23,944 | Mar 3, 2025 |
| Mar 1, 2025 | MOption exercise Restricted Stock Unitsderivative | -6,750 | $0.00 | $0 | 20,250 | Mar 3, 2025 |
Related signals
Other insiders at Whitehawk Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 15Weak | Whitehawk Therapeutics, Inc. | Bryan Ball See remarks | $5,045 2,147 shares | -2% | |
| 30Weak | Whitehawk Therapeutics, Inc. | David James Lennon CHIEF EXECUTIVE OFFICER | $13k 5,690 shares | -15% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.